Navigation Links
Controversy: Malaria Vaccine - Future Possibility Or Just A Dream?

While scientists world over have hailed the results of a trial of a malaria vaccine by pharmaceutical company GlaxoSmithKline (GSK), that has halved the incidence of severe disease in children, Pierre Druilhi, a French // entist, warned that malaria vaccination is still a far off dream failing better international coordination.

Shunning claims of a medical breakthrough, Pierre Druilhi, director of the Biomedical Parasitological Unit at the Pasteur Institute in Paris said that it is too early to say we have a vaccine against malaria. He presented his speech at the fourth annual pan-African malaria conference, organized by the Multilateral Initiative on Malaria, (MIM), held in the Cameroonian capital Yaounde.

GSK presented trials of the RTS S/AS02A vaccine carried out on 1,442 children between one and four years of age in Mozambique in 2003. A six-month follow up study and another 12 months later Early trials of the vaccine last year showed it was effective over six months. The new study of the children who have been followed up for 18 months, published online in the journal Lancet, revealed that the protection was maintained, with a 30 % reduced risk of clinical malaria.

GSK worked with CISM, the Hospital Clinic of the University of Barcelona, the Ministry of Health in Mozambique and the Malaria Vaccine Initiative to develop the vaccine.

Pedro Alonso, scientific director of the Manhica Health Research Centre (CISM), said that 'The unprecedented results in this study is further evidence that an effective vaccine to help control the malaria pandemic, which kills more than one million people in developing countries, is very possible'.

While researchers have accepted that, at least for the foreseeable future, there is no prospect of a vaccine, which could wipe out malaria or even provide lifelong immunity, a vaccine that would turn the disease into a mostly mild infection would play an important role in the eff ort to control malaria.

The vaccine could be on the market in 2011 if additional trials prove its effectiveness.

Medindia on Malaria:

Malaria is usually caused by a mosquito bite and the parasite microbe is passed from the mosquito to the blood through a sharp hypoderme needle like sting. It is transmitted by transfusion of infected blood.

More on Medindia:

http://www.medindia.com/news/view_news_main.asp?x=5789

http://www.medindia.net/patients/patientinfo/malaria.asp

http://www.medindia.net/patients/patientinfo/mosquito_about.htm

http://www.medindia.net/patients/waterborne/Malaria.asp

http://www.medindia.net/news/view_news_main.asp?str=2&x=5799
'"/>




Related medicine news :

1. Malaria strikes Munger tribals
2. Sponging Cattle betters spraying in eradicating Malaria
3. Gene researchers make Malaria-resistant mosquito
4. More Treatment Options For Malaria
5. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
6. Jharkhand reports 13,000 Malaria cases
7. Researchers Discover Protein That Causes Malaria
8. Malarial gene ascertained
9. Artesunate Is Better For Malaria Than Quinine
10. New Strategies For Effective Treatment Of Malaria
11. Chloroquine and Primaquine combination Malarial drug for resistant parasites.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/24/2017)... IL (PRWEB) , ... May 24, 2017 , ... ... the most prominent for-profit and nonprofit hospitals and health systems in the nation ... turned around their institutions, led professional organizations and been instrumental in developing successful ...
(Date:5/23/2017)... (PRWEB) , ... May 23, 2017 , ... ... Population Health and Clinical Integration company, announced today that its iClinic V12.2 solution ... (PCMH) 2017 Prevalidation. NCQA recently introduced PCMH 2017 standards which emphasize team-based ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... have remained steady since 2009, according to a Workers Compensation Research Institute (WCRI) ... Monitoring the North Carolina System: CompScope™ Benchmarks, 17th Edition looks at ...
(Date:5/23/2017)... ... , ... London, May 23, 2017: Walter Schindler, the Founder and Managing Partner ... Speaker and Contributor to a weeklong series of classes, meetings, field trips and special ... Walter Schindler and SAIL Capital have received an increasing number of ...
(Date:5/23/2017)... ... May 23, 2017 , ... MedTech For Solutions has announced ... laboratory, to provide hands-on training utilizing cutting-edge equipment at its recently-opened OvaTools Andrology ... MedTech Group Purchasing vendor , will provide specialized equipment to ensure OvaTools participants ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... Mass., May 10, 2017 Hologic, Inc. (Nasdaq: ... results for the fiscal second quarter ended April 1, ... of $1.84 increased 666.7% compared to the prior year ... resulted in a significant gain, while non-GAAP diluted EPS ... 3.2%, or 3.8% in constant currency terms.  Excluding the ...
(Date:5/10/2017)... Radiology has become the number one diagnostic ... spiraled to the number one ranking as a result.  ... before as the most complete and reliable method for ... back pain an MRI may confirm a suspected herniated ... in entirely different treatment protocols.  In these circumstances, patients ...
(Date:5/9/2017)...  Demonstrating its commitment to representing research- based ... Pharmaceutical Research and Manufacturers of America (PhRMA) today ... now have to meet new research and development ... join PhRMA. "By putting in place ... clear message that being a member of PhRMA ...
Breaking Medicine Technology: